CIK 0001055726
- Non-accelerated filer
- Smaller reporting company
INOVIO PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- INO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330969592
- Phone
- +1 858-410-3134
- Business address
- 660 W. GERMANTOWN PIKE, SUITE 110, PLYMOUTH MEETING, PA, 19462
- Former names
- INOVIO BIOMEDICAL CORP, GENETRONICS BIOMEDICAL CORP, GENETRONICS BIOMEDICAL LTD
- 4 Shares withheld for taxes Chief Scientific Officer gave up 1,703 shares (to pay taxes)
- 4 Option exercise Chief Medical Officer acquired 2,386 shares (option exercise)
- 4 Option exercise Director acquired 2,166 shares (option exercise)
- 4 Option exercise Director acquired 2,166 shares (option exercise)
- 4 Option exercise Director acquired 2,166 shares (option exercise)
- 4 Option exercise Director acquired 2,166 shares (option exercise)
- 4 Shares withheld for taxes Chief Executive Officer gave up 7,718 shares (to pay taxes)
- 4 Option exercise Director acquired 1,000 shares (option exercise)
- 4 Shares withheld for taxes Chief Executive Officer gave up 2,392 shares (to pay taxes)
- 4 Option exercise Director acquired 2,916 shares (option exercise)
- 4 Shares withheld for taxes Chief Executive Officer gave up 3,728 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 2,351 shares (to pay taxes)
- 4 Shares withheld for taxes CFO gave up 3,466 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Option exercise Chief Medical Officer acquired 35,000 shares (option exercise)
- 4 Open-market sale Director sold 5,700 shares at $0.56 ($3,192)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 4 of 30 · 592 filings